What is the estimated financial liability or settlement cost for Insperity if the claims succeed?

The filing does not disclose a concrete dollar figure for any potential judgment or settlement, so there is no publicly‑available “estimated liability” that can be quoted at this time. Pomerantz’s investigation is simply being announced, and the company’s own disclosures (e.g., Form 8‑K or any subsequent SEC filing) have not yet provided a ball‑park range for possible damages. Consequently, any market‑pricing of the risk must be inferred from the nature of the claim (investor‑class‑action allegations) and the typical exposure such cases generate for a mid‑cap human‑resources services firm, which historically can range from a few million dollars to low‑double‑digit millions if the case proceeds to settlement.

From a trading perspective, the lack of a defined exposure means the stock’s price reaction will be driven largely by the probability‑of‑loss narrative rather than a specific cost estimate. Until the company files a detailed disclosure (e.g., a Section 13(e) notice or a press release with an estimated range), traders should treat the upside risk as limited—any resolution is likely to be a modest hit to earnings rather than a material blow to the balance sheet. Accordingly, a cautious short‑to‑neutral stance (e.g., selling covered calls or reducing exposure) may be prudent, while keeping an eye on upcoming SEC filings for a more precise liability figure that could trigger a sharper move.